PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
21162127-6	2011	In vitro study indicated that treatment with ATP and BzATP (an agonist for ATP ionotropic receptor P2X7R) caused an increase in the intracellular levels of microglial MIP-1alpha and MCP-1.	3'-O-(4-benzoyl)benzoyladenosine 5'-triphosphate	53-58	C-C motif chemokine ligand 3	Rattus norvegicus	167-177	
21162127-7	2011	By using an extracellular Ca(2+) chelator (EGTA) and P2X7R antagonists, oxidized ATP (oxATP) and brilliant blue G (BBG), we demonstrated that BzATP-induced production of MIP-1alpha and MCP-1 levels was due to P2X7R activation and Ca(2+) -dependent regulation.	3'-O-(4-benzoyl)benzoyladenosine 5'-triphosphate	142-147	C-C motif chemokine ligand 3	Rattus norvegicus	170-180	
33166661-9	2021	BzATP produced an increase in IL-1alpha and IL-1beta release and rapidly suppressed the release of CXCL1, CCL2, CCL3, CCL20, and IL-6.	3'-O-(4-benzoyl)benzoyladenosine 5'-triphosphate	0-5	C-C motif chemokine ligand 3	Rattus norvegicus	112-116